Reported risk behaviors or exposures among reported cases* of acute hepatitis C virus infection — United States, 2020
Downloads of this table: PDF PPT
Source: CDC, National Notifiable Diseases Surveillance System.
* Reported confirmed cases. For the case definition, see Acute Hepatitis C.
† Reported cases may include more than one risk behavior/exposure. Case reports with at least one of the following risk behaviors/ exposures reported 6 weeks to 6 months prior to symptom onset or documented seroconversion if asymptomatic: 1) injection drug use; 2) multiple sexual partners; 3) underwent surgery; 4) men who have sex with men; 5) sexual contact with suspected/confirmed hepatitis C case; 6) sustained a percutaneous injury; 7) household contact with suspected/confirmed hepatitis C case; 8) occupational exposure to blood; 9) dialysis; and 10) transfusion.
§ Cases with more than one type of contact reported were categorized according to a hierarchy: (1) sexual contact; (2) household contact (nonsexual).
¶ A total of 2,989 acute hepatitis C cases were reported among males in 2020.
Health departments might conduct investigations of newly reported acute hepatitis C cases to ascertain risk behaviors and exposures associated with infection. However, investigations might not be possible for all cases if patients are lost to follow-up or if health departments lack adequate resources for investigating all cases reported in their jurisdiction. Among the 4,798 case reports of acute hepatitis C received by CDC for 2020, data regarding risk behaviors or exposures were missing for 3,038 (63.6%) cases. At least one risk behavior or exposure was reported for 1,278 (26.6%) cases during the 6 weeks to 6 months before illness onset. More than one risk can be reported for each case.
Among risk behaviors and exposures identified, injection drug use was most commonly reported (66% of the 1,540 cases for which injection drug use information was available). Hepatitis C virus transmission associated with surgery, dialysis, or transfusion is extremely rare in the United States; thus, the reporting of these exposures might represent a history of recent exposure to these health care procedures and do not necessarily indicate these procedures were associated with HCV transmission.
- Figure 3.1. Number of reported cases of acute hepatitis C virus infection and estimated infections — United States, 2013-2020
- Figure 3.2. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2019-2020
- Figure 3.3. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2020
- Figure 3.4. Rates of reported cases of acute hepatitis C virus infection, by age group — United States, 2005-2020
- Figure 3.5. Rates of reported cases of acute hepatitis C virus infection, by sex — United States, 2005-2020
- Figure 3.6. Rates of reported cases of acute hepatitis C virus infection, by race/ethnicity — United States, 2005-2020
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2020
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases by sex and age — United States, 2020
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2020
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2016-2020
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C virus infection, by demographic characteristics — United States 2016-2020
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2020
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2020
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2020
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2020
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2016-2020
- Table 3.8. Numbers and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2016-2020